Efficacy and Safety of First-Line Everolimus Therapy Alone or in Combination with Octreotide in Gastroenteropancreatic Neuroendocrine Tumors. A Hellenic Cooperative Oncology Group (HeCOG) Study

The purpose of this study was to explore the efficacy and safety of everolimus administered as a first-line treatment in newly diagnosed patients with metastatic or inoperable gastroenteropancreatic neuroendocrine tumors (GEP NETs). This phase II, multicenter, single-arm study included patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Koumarianou, Anna, Pectasides, Dimitrios, Koliou, Georgia-Angeliki, Dionysopoulos, Dimitrios, Kolomodi, Dionysia, Poulios, Christos, Skondra, Maria, Sgouros, Joseph, Pentheroudakis, George, Kaltsas, Gregory, Fountzilas, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150771/
https://www.ncbi.nlm.nih.gov/pubmed/32182791
http://dx.doi.org/10.3390/biology9030051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150771/
https://www.ncbi.nlm.nih.gov/pubmed/32182791
http://dx.doi.org/10.3390/biology9030051

Ejemplares similares